IBDEI30Y ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48296,1,3,0)
 ;;=3^Penis,Ulcer
 ;;^UTILITY(U,$J,358.3,48296,1,4,0)
 ;;=4^N48.5
 ;;^UTILITY(U,$J,358.3,48296,2)
 ;;=^5015738
 ;;^UTILITY(U,$J,358.3,48297,0)
 ;;=N84.9^^185^2420^79
 ;;^UTILITY(U,$J,358.3,48297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48297,1,3,0)
 ;;=3^Polyp,Female Genital Tract,Unspec
 ;;^UTILITY(U,$J,358.3,48297,1,4,0)
 ;;=4^N84.9
 ;;^UTILITY(U,$J,358.3,48297,2)
 ;;=^5015869
 ;;^UTILITY(U,$J,358.3,48298,0)
 ;;=N95.2^^185^2420^80
 ;;^UTILITY(U,$J,358.3,48298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48298,1,3,0)
 ;;=3^Postmenopausal Atrophic Vaginitis
 ;;^UTILITY(U,$J,358.3,48298,1,4,0)
 ;;=4^N95.2
 ;;^UTILITY(U,$J,358.3,48298,2)
 ;;=^270577
 ;;^UTILITY(U,$J,358.3,48299,0)
 ;;=N95.0^^185^2420^81
 ;;^UTILITY(U,$J,358.3,48299,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48299,1,3,0)
 ;;=3^Postmenopausal Bleeding
 ;;^UTILITY(U,$J,358.3,48299,1,4,0)
 ;;=4^N95.0
 ;;^UTILITY(U,$J,358.3,48299,2)
 ;;=^97040
 ;;^UTILITY(U,$J,358.3,48300,0)
 ;;=N42.9^^185^2420^84
 ;;^UTILITY(U,$J,358.3,48300,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48300,1,3,0)
 ;;=3^Prostate Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,48300,1,4,0)
 ;;=4^N42.9
 ;;^UTILITY(U,$J,358.3,48300,2)
 ;;=^5015698
 ;;^UTILITY(U,$J,358.3,48301,0)
 ;;=N40.1^^185^2420^86
 ;;^UTILITY(U,$J,358.3,48301,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48301,1,3,0)
 ;;=3^Prostate,Enlarged w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,48301,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,48301,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,48302,0)
 ;;=N40.0^^185^2420^87
 ;;^UTILITY(U,$J,358.3,48302,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48302,1,3,0)
 ;;=3^Prostate,Enlarged w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,48302,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,48302,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,48303,0)
 ;;=N41.9^^185^2420^85
 ;;^UTILITY(U,$J,358.3,48303,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48303,1,3,0)
 ;;=3^Prostate Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,48303,1,4,0)
 ;;=4^N41.9
 ;;^UTILITY(U,$J,358.3,48303,2)
 ;;=^5015694
 ;;^UTILITY(U,$J,358.3,48304,0)
 ;;=C61.^^185^2420^83
 ;;^UTILITY(U,$J,358.3,48304,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48304,1,3,0)
 ;;=3^Prostate Cancer
 ;;^UTILITY(U,$J,358.3,48304,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,48304,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,48305,0)
 ;;=N40.3^^185^2420^88
 ;;^UTILITY(U,$J,358.3,48305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48305,1,3,0)
 ;;=3^Prostate,Nodular w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,48305,1,4,0)
 ;;=4^N40.3
 ;;^UTILITY(U,$J,358.3,48305,2)
 ;;=^5015692
 ;;^UTILITY(U,$J,358.3,48306,0)
 ;;=N40.2^^185^2420^89
 ;;^UTILITY(U,$J,358.3,48306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48306,1,3,0)
 ;;=3^Prostate,Nodular w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,48306,1,4,0)
 ;;=4^N40.2
 ;;^UTILITY(U,$J,358.3,48306,2)
 ;;=^5015691
 ;;^UTILITY(U,$J,358.3,48307,0)
 ;;=Z87.430^^185^2420^76
 ;;^UTILITY(U,$J,358.3,48307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48307,1,3,0)
 ;;=3^Personal Hx of Prostatic Dysplasia
 ;;^UTILITY(U,$J,358.3,48307,1,4,0)
 ;;=4^Z87.430
 ;;^UTILITY(U,$J,358.3,48307,2)
 ;;=^5063493
 ;;^UTILITY(U,$J,358.3,48308,0)
 ;;=N41.2^^185^2420^1
 ;;^UTILITY(U,$J,358.3,48308,1,0)
 ;;=^358.31IA^4^2
